Abbott Laboratories Financial Ratios — ABT Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	16.11	17.9	7.37	6.59	11.99	3.63	1.11	4.97	7.54	8.86	13.12	11.96	9.35	19.88	8.83
Return on Assets (%)	7.82	9.35	4.68	5.43	10.73	2.98	0.74	3.3	5.46	6.4	9.57	9.27	7.75	17.33	7.76
Return on Capital (%)	10.85	- -	5.59	5.69	10.04	3.18	0.91	4.25	6.28	7.1	10.25	9.66	8.03	- -	7.78
Return on Invested Capital (%)	3.59	- -	5.24	5.81	7.84	6.23	0.49	5.43	8.17	9.4	13.51	12.77	10.21	- -	9.56
Gross Margin (%)	53.21	53.29	53.23	54.47	57.13	56.39	54.7	58.45	58.53	56.65	56.97	56.15	55.18	55.41	56.42
EBITDA Margin (%)	21.83	21.74	19.6	20.48	21.26	21	16.74	22.66	23.65	25.09	27.77	26.64	24.24	23.94	25.2
Operating Margin (%)	7.61	7.14	10.85	12.84	14.05	14.51	5.71	11.94	14.21	15.48	19.56	19.16	16.15	16.27	18.17
Incremental Operating Margin (%)	34.68	11.41	127.35	78.98	169.62	35.49	-22.36	65.43	66.52	30.51	36.23	-10.9	53.16	18.85	51.64
Pretax Margin (%)	5.77	-1.15	10.38	12.44	15.6	6.78	8.15	9.4	12.78	14.36	19.06	19.03	16.61	16.72	19.1
Profit Margin (%)	22.09	31.3	13.1	11.28	21.68	6.71	1.74	7.74	11.56	12.99	16.42	15.88	14.27	31.95	14.72
Net Income to Common Margin (%)	22.09	31.3	13.1	11.28	21.68	6.71	1.74	7.74	11.56	12.99	16.42	15.88	14.27	31.95	14.72
Effective Tax Rate (%)	8.9	- -	2.6	31.65	18.13	24.77	84.18	18.76	9.57	10	13.88	16.53	14.12	- -	22.94
Dvd Payout Ratio (%)	260.92	1,343.04	44.37	77.98	55.37	144.78	523.8	84.58	61.57	57.26	45.28	47.73	62.14	28.62	63.09
Sustainable Growth Rate (%)	-25.93	-222.49	4.1	1.45	5.35	-1.63	-4.71	0.77	2.9	3.79	7.18	6.25	3.54	14.19	3.26

Credit (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	15,415	20,476	6,561	7,830	9,001	22,006	27,924	19,566	18,894	19,649	19,006	17,716	15,628	15,021	13,860
ST Debt	3,375	2,391	3,173	4,437	3,130	1,325	714	207	1,478	220	754	2,251	1,080	1,500	3,033
LT Debt	12,040	18,085	3,388	3,393	5,871	20,681	27,210	19,359	17,416	19,429	18,252	15,465	14,548	13,521	10,827
Total Debt/EBITDA	3.3	4.94	1.7	1.89	2.07	5.03	6.09	2.82	2.5	2.26	1.59	1.52	1.61	1.5	1.24
Net Debt/EBITDA	1.84	2.34	0.8	0.91	0.92	0.77	4.04	2.27	1.89	1.37	0.69	0.59	0.8	0.65	0.39
Total Debt/EBIT	9.46	15.06	3.08	3.01	3.14	7.27	17.85	5.36	4.17	3.67	2.26	2.12	2.41	2.2	1.72
Net Debt/EBIT	5.28	7.11	1.45	1.45	1.4	1.12	11.84	4.31	3.15	2.22	0.98	0.82	1.2	0.95	0.55
EBITDA to Interest Expense	13.02	12.94	26.57	27.65	26.62	10.16	5.07	8.39	11.26	15.9	22.44	20.84	15.26	17.97	22.66
EBITDA-CapEx/Interest Expense	8.86	7.33	18.67	20.47	19.81	7.56	3.82	6.7	8.82	11.92	18.91	17.66	11.8	14.02	18.25
EBIT to Interest Expense	4.54	4.25	14.71	17.33	17.59	7.02	1.73	4.42	6.76	9.81	15.81	14.99	10.17	12.21	16.33
Interest Expense	359	320	145	150	163	431	904	826	670	546	533	558	637	559	493
Common Equity/Total Assets	50.97	53.4	79.22	85.56	93.32	73.28	61.88	71.56	73.21	71.36	74.47	80.56	85.26	88.95	86.85
Long-Term Debt/Equity (%)	49.09	67.45	13.41	15.68	27.53	99.83	87.5	63.01	55.64	58.87	50.67	41.9	37.47	28.23	20.52
Long-Term Debt/Capital (%)	26.05	32.02	8.33	7.85	12.33	34.03	36.13	28.54	25.31	27.12	24.26	19.85	18.59	15.42	12.06
Long-Term Debt/Total Assets (%)	19.97	26.9	7.89	8.23	14.23	39.27	35.69	28.82	25.65	26.78	24.27	20.78	19.87	16.61	12.49
Total Debt/Equity (%)	62.85	76.37	25.97	36.18	42.21	106.22	89.79	63.69	60.36	59.54	52.76	48	40.25	31.36	26.26
Total Debt/Capital (%)	33.35	36.26	16.13	18.12	18.91	36.21	37.08	28.84	27.46	27.43	25.27	22.74	19.97	17.13	15.43
Total Debt/Total Assets (%)	25.57	30.45	15.27	19	21.82	41.78	36.62	29.13	27.83	27.08	25.28	23.8	21.35	18.45	15.98
Net Debt to Equity	35.07	36.08	12.21	17.41	18.76	16.34	59.54	51.18	45.62	36.08	22.9	18.67	20.05	13.59	8.35
Net Debt/Capital (%)	21.82	21.18	8.29	9.63	9.39	8.03	28.1	24.57	21.99	18.38	12.61	10.13	10.9	8.13	5.42
EBITDA	4,673	4,142	3,852	4,147	4,339	4,379	4,585	6,928	7,546	8,684	11,963	11,629	9,721	10,043	11,169
EBITDA-CapEx	3,182	2,347	2,707	3,070	3,229	3,258	3,450	5,534	5,908	6,507	10,078	9,852	7,519	7,836	8,998
Operating Income (Loss)	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478	6,825	8,053

Liquidity (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.52	1.14	0.85	0.43	0.67	2.82	1.08	0.45	0.38	0.6	0.78	0.66	0.53	0.56	0.54
Current Ratio	1.54	2.36	2.02	1.3	1.54	4.02	2.26	1.62	1.44	1.72	1.85	1.63	1.64	1.67	1.58
Quick Ratio	1.15	1.85	1.43	0.96	1.25	3.58	1.85	1.2	1.04	1.3	1.46	1.23	1.16	1.23	1.18
CFO/Avg Current Liab	0.55	0.65	0.29	0.37	0.3	0.4	0.72	0.7	0.62	0.69	0.84	0.67	0.5	0.61	0.62
Common Equity/Total Assets	50.97	53.4	79.22	85.56	93.32	73.28	61.88	71.56	73.21	71.36	74.47	80.56	85.26	88.95	86.85
Long-Term Debt/Equity (%)	49.09	67.45	13.41	15.68	27.53	99.83	87.5	63.01	55.64	58.87	50.67	41.9	37.47	28.23	20.52
Long-Term Debt/Capital (%)	26.05	32.02	8.33	7.85	12.33	34.03	36.13	28.54	25.31	27.12	24.26	19.85	18.59	15.42	12.06
Long-Term Debt/Total Assets (%)	19.97	26.9	7.89	8.23	14.23	39.27	35.69	28.82	25.65	26.78	24.27	20.78	19.87	16.61	12.49
Total Debt/Equity (%)	62.85	76.37	25.97	36.18	42.21	106.22	89.79	63.69	60.36	59.54	52.76	48	40.25	31.36	26.26
Total Debt/Capital (%)	33.35	36.26	16.13	18.12	18.91	36.21	37.08	28.84	27.46	27.43	25.27	22.74	19.97	17.13	15.43
Total Debt/Total Assets (%)	25.57	30.45	15.27	19	21.82	41.78	36.62	29.13	27.83	27.08	25.28	23.8	21.35	18.45	15.98
CFO/Total Liabilities	25.09	23.04	18.79	18.78	14.89	10.03	12.34	17.28	16.77	19.98	26.89	25.53	21.12	25.54	28.18
CFO/CapEx	6.02	5.19	2.9	3.41	2.67	2.86	4.91	4.52	3.75	3.63	5.59	5.39	3.3	3.88	4.41
Altman's Z-Score	2.62	2.58	4.53	4.67	4.75	3.31	3.91	5.44	5.72	5.92	7.08	6.26	6.39	6.26	6.51

Working Capital (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	2.88	2.49	3.39	5.35	5.83	6.26	6.45	5.86	6.02	5.85	6.68	6.87	6.28	6.22	5.97
Days Sales Outstanding	126.75	146.55	107.69	68.25	62.64	58.34	56.62	62.26	60.68	62.43	54.66	53.12	58.16	58.69	61.15
Inventory Turnover	3.1	2.51	2.83	3.46	3.34	3.61	4.11	3.44	3.26	3.22	3.65	3.38	2.82	2.93	3.05
Days Inventory Outstanding	117.93	145.14	128.76	105.64	109.37	101	88.76	106.25	111.89	113.47	100.12	108.02	129.38	124.53	119.8
Accounts Payable Turnover	6.21	5.35	5.73	8.77	8.11	7.91	7.58	4.8	4.42	4.36	4.47	4.47	4.13	4.32	4.65
Accounts Payable Turnover Days	58.78	68.25	63.66	41.6	44.98	46.17	48.13	76.06	82.64	83.68	81.61	81.62	88.43	84.53	78.49
Cash Conversion Cycle	185.91	223.44	172.79	132.29	127.03	113.17	97.25	92.44	89.92	92.22	73.17	79.52	99.11	98.69	102.47
Inventory to Cash Days	8.82	1.41	-21.07	-37.39	-46.73	-42.66	-32.14	-43.99	-51.22	-51.04	-45.46	-54.9	-71.22	-65.84	-58.65
Inventories	3,284	3,793	2,693	2,643	2,599	2,434	3,601	3,796	4,316	5,012	5,157	6,173	6,570	6,194	6,488
Raw Materials	631	818	478	558	539	516	790	890	972	1,270	1,382	1,688	1,817	1,654	1,608
Work In Process	432	629	349	278	316	294	472	499	560	712	694	680	807	840	904
Finished Goods	2,221	2,346	1,866	1,807	1,744	1,624	2,339	2,407	2,784	3,030	3,081	3,805	3,946	3,700	3,976
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	42,243	49,413	59,339	67,892	66,137	56,573	99,507	126,984	153,091	193,932	248,277	190,793	190,870	195,872	217,579
- Cash & Cash Equivalents	6,813	10,802	3,475	4,063	5,001	18,620	9,407	3,844	3,860	6,838	9,799	9,882	6,896	7,616	8,522
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	86	92	96	113	115	179	201	198	213	219	222	219	224	237	641
+ Total Debt	15,415	20,476	6,561	7,830	9,001	22,006	27,924	19,566	18,894	19,649	19,006	17,716	15,628	15,021	13,860
Enterprise Value	49,647	54,807	57,898	71,375	69,128	59,983	118,022	142,662	168,058	206,652	257,256	198,558	199,443	203,163	223,141
Total Capital	46,225	56,474	40,684	43,200	47,607	60,777	75,309	67,836	68,807	71,640	75,226	77,901	78,275	87,672	89,809
Total Debt/Capital (%)	33.35	36.26	16.13	18.12	18.91	36.21	37.08	28.84	27.46	27.43	25.27	22.74	19.97	17.13	15.43
Total Debt / EV	0.31	0.37	0.11	0.11	0.13	0.37	0.24	0.14	0.11	0.1	0.07	0.09	0.08	0.07	0.06
EV/Sales	2.32	2.88	2.95	3.53	3.39	2.88	4.31	4.67	5.27	5.97	5.97	4.55	4.97	4.84	5.03
EV/EBITDA	10.62	13.23	15.03	17.21	15.93	13.7	25.74	20.59	22.27	23.8	21.5	17.07	20.52	20.23	19.98
EV/EBIT	30.48	40.3	27.14	27.46	24.11	19.82	75.46	39.09	37.08	38.58	30.53	23.75	30.79	29.77	27.71
EV/Cash Flow to Firm	5.34	6.11	16.71	18.89	22.3	17.01	20.66	20.46	24.93	24.62	23.4	19.76	25.54	21.11	22.44
EV/Free Cash Flow to Firm	4.6	5.09	12.56	14.7	16.42	12.9	17.23	17.05	20.05	19.55	19.98	16.79	19.92	17.17	18.42
Diluted Market Cap	42,243	49,893	60,331	68,746	67,634	56,962	99,815	128,024	154,698	195,549	251,784	193,670	192,512	197,716	219,132
Diluted Enterprise Value	50,931	59,659	63,513	72,626	71,749	60,527	118,533	143,944	169,945	208,579	261,213	201,723	201,468	205,358	225,111
EV per Share	31.61	34.76	37.4	47.33	46.94	40.73	67.69	81.26	95.35	116.67	145.83	114.26	115.01	117.32	128.49
TTM Sales	21,407	19,050	19,657	20,247	20,405	20,853	27,390	30,578	31,904	34,608	43,075	43,653	40,109	41,950	44,328
TTM EBITDA	4,673	4,142	3,852	4,147	4,339	4,379	4,585	6,928	7,546	8,684	11,963	11,629	9,721	10,043	11,169
TTM Operating Income	1,629	1,360	2,133	2,599	2,867	3,026	1,564	3,650	4,532	5,357	8,425	8,362	6,478	6,825	8,053
TTM Cash Flow to Firm	9,297	8,969	3,465	3,778	3,099	3,527	5,713	6,971	6,742	8,392	10,992	10,047	7,808	9,626	9,946
TTM Free Cash Flow to Firm	10,788	10,764	4,610	4,855	4,209	4,648	6,848	8,365	8,380	10,569	12,877	11,824	10,010	11,833	12,117

Multiples (USD)

MCP API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	4.04	4.49	13.5	14.47	16.59	13.17	14.89	16.64	19.9	19.4	20.28	17.05	20.34	18.37	18.67
EV/EBIT	30.48	40.3	27.14	27.46	24.11	19.82	75.46	39.09	37.08	38.58	30.53	23.75	30.79	29.77	27.71
Enterprise Value	49,647	54,807	57,898	71,375	69,128	59,983	118,022	142,662	168,058	206,652	257,256	198,558	199,443	203,163	223,141
Low Price	21.56	25.81	31.64	35.65	39	36	38.34	55.58	65.5	61.61	105.36	93.25	89.67	99.71	110.86
EV/Sales	2.32	2.88	2.95	3.53	3.39	2.88	4.31	4.67	5.27	5.97	5.97	4.55	4.97	4.84	5.03
EV/EBITDA	10.62	13.23	15.03	17.21	15.93	13.7	25.74	20.59	22.27	23.8	21.5	17.07	20.52	20.23	19.98
Price/Earnings	8.93	8.29	23.04	29.72	14.95	40.41	208.61	53.62	41.52	43.14	35.11	27.52	33.35	14.62	33.35
Price/Earnings Average	8.11	7.94	21.43	27.04	15.42	42.6	177.44	47.61	38.5	37.87	30.32	28.03	31.59	14.4	34.46
Price/Earnings High	8.97	9.17	23.32	30.7	17.23	48.17	211.17	55.55	42.66	45.37	35.58	35.05	35.1	15.72	37.59
Price/Earnings Low	7.16	6.82	19.01	23.54	12.99	37.87	140.15	41.21	31.31	24.28	26.29	23.37	27.17	12.88	29.51
Price/Book Value	1.37	1.38	1.74	1.93	1.72	1.47	2.11	2.64	3.08	3.75	4.43	3.18	3.06	2.7	2.89
Price/Book Value Average	1.25	1.32	1.62	1.75	1.77	1.55	1.79	2.35	2.86	3.29	3.83	3.24	2.9	2.67	2.99
Price/Book Value High	1.38	1.52	1.77	1.99	1.98	1.75	2.13	2.74	3.16	3.94	4.49	4.05	3.22	2.91	3.26
Price/Book Value Low	1.1	1.13	1.44	1.52	1.49	1.37	1.42	2.03	2.32	2.11	3.32	2.7	2.49	2.38	2.56
Price/Tangible Book Value	-36.14	20.16	6.08	12.63	10.8	6.66	-6.91	-11.07	-17.16	-35.1	4,597.72	52.24	30.14	10.79	9.37
Price/Tangible Book Value Average	-32.82	19.31	5.66	11.49	11.13	7.02	-5.88	-9.83	-15.92	-30.81	3,970.13	53.22	28.55	10.64	9.69
Price/Tangible Book Value High	-36.27	22.3	6.16	13.05	12.44	7.94	-7	-11.46	-17.63	-36.91	4,658.48	66.54	31.72	11.61	10.57
Price/Tangible Book Value Low	-28.97	16.6	5.02	10	9.38	6.24	-4.64	-8.5	-12.94	-19.75	3,441.92	44.37	24.55	9.52	8.29
Price/Sales	1.97	2.59	3.02	3.35	3.24	2.71	3.63	4.15	4.8	5.6	5.76	4.37	4.76	4.67	4.91
Price/Sales Average	1.79	2.48	2.81	3.05	3.34	2.86	3.09	3.69	4.45	4.92	4.98	4.45	4.51	4.6	5.07
Price/Sales High	1.98	2.87	3.06	3.46	3.73	3.23	3.68	4.3	4.93	5.89	5.84	5.57	5.01	5.02	5.53
Price/Sales Low	1.58	2.14	2.49	2.66	2.81	2.54	2.44	3.19	3.62	3.15	4.31	3.71	3.88	4.12	4.34
Price/Cash Flow	4.71	5.31	17.85	18.47	22.3	17.66	17.86	20.16	24.95	24.55	23.57	19.91	26.29	22.89	22.74
Price/Cash Flow Average	4.28	5.08	16.61	16.81	22.99	18.62	15.2	17.9	23.13	21.55	20.35	20.29	24.9	22.55	23.5
Price/Cash Flow High	4.73	5.87	18.08	19.08	25.69	21.06	18.08	20.88	25.63	25.81	23.88	25.36	27.66	24.61	25.64
Price/Cash Flow Low	3.77	4.37	14.74	14.63	19.36	16.55	12	15.49	18.81	13.81	17.65	16.91	21.42	20.18	20.13
Price/Free Cash Flow Average	3.67	4.3	12.56	13.16	17.11	13.89	12.66	14.77	18.45	17.03	17.51	17.37	19.27	18.1	19.29
Price/Free Cash Flow High	4.05	4.97	13.67	14.94	19.12	15.7	15.07	17.24	20.44	20.4	20.54	21.72	21.41	19.75	21.05
Price/Free Cash Flow Low	3.24	3.7	11.14	11.46	14.41	12.35	10	12.79	15.01	10.92	15.18	14.48	16.57	16.19	16.52
EV/Sales Average	2.2	3	2.97	3.24	3.54	3.03	3.77	4.21	4.93	5.3	5.2	4.64	4.73	4.78	5.21
EV/Sales High	2.39	3.38	3.22	3.66	3.94	3.41	4.36	4.82	5.41	6.27	6.06	5.75	5.23	5.2	5.67
EV/Sales Low	1.99	2.65	2.65	2.85	3.02	2.71	3.12	3.71	4.1	3.53	4.53	3.9	4.1	4.3	4.48
EV/EBITDA Average	10.07	13.79	15.16	15.83	16.66	14.43	22.54	18.57	20.83	21.1	18.71	17.41	19.52	19.98	20.67
EV/EBITDA High	10.93	15.56	16.42	17.85	18.51	16.22	26.05	21.28	22.86	24.98	21.82	21.59	21.58	21.74	22.49
EV/EBITDA Low	9.1	12.18	13.54	13.9	14.19	12.92	18.66	16.38	17.32	14.07	16.32	14.63	16.92	17.95	17.77
EV/EBIT Average	28.88	41.99	27.37	25.26	25.22	20.89	66.09	35.25	34.69	34.21	26.57	24.21	29.29	29.4	28.66
EV/EBIT High	31.36	47.37	29.66	28.47	28.01	23.47	76.37	40.4	38.07	40.5	30.98	30.02	32.39	31.98	31.2
EV/EBIT Low	26.12	37.1	24.46	22.18	21.47	18.7	54.71	31.1	28.84	22.8	23.18	20.34	25.39	26.42	24.65
Last Price	26.9	31.34	38.33	45.02	44.91	38.41	57.07	72.33	86.86	109.49	140.74	109.79	110.07	113.11	125.29
High Price	27	34.67	38.81	46.5	51.74	45.79	57.77	74.92	89.24	115.14	142.6	139.83	115.83	121.64	141.23
Enterprise Value Average	47,052	57,104	58,378	65,641	72,309	63,208	103,359	128,668	157,199	183,270	223,816	202,409	189,761	200,659	230,809
Enterprise Value High	51,088	64,429	63,264	74,004	80,311	71,008	119,446	147,451	172,533	216,969	260,987	251,049	209,814	218,286	251,239
Enterprise Value Low	42,545	50,460	52,164	57,641	61,549	56,588	85,568	113,497	130,691	122,155	195,293	170,102	164,451	180,310	198,498

Shares Outstanding	1,570	1,577	1,548	1,508	1,473	1,473	1,744	1,756	1,763	1,771	1,764	1,738	1,734	1,732	1,737
Diluted Weighted Avg Shares	1,570	1,592	1,574	1,527	1,506	1,483	1,749	1,770	1,781	1,786	1,789	1,764	1,749	1,748	1,749
Basic Weighted Avg Shares	1,570	1,577	1,548	1,508	1,473	1,473	1,744	1,756	1,763	1,771	1,764	1,738	1,734	1,732	1,737
Revenue per Share	13.63	12.08	12.7	13.43	13.86	14.16	15.71	17.42	18.1	19.54	24.42	25.12	23.13	24.22	25.53
EBITDA per Share	2.98	2.63	2.49	2.75	2.95	2.97	2.63	3.95	4.28	4.9	6.78	6.69	5.61	5.8	6.43
Operating Income per Share	1.04	0.86	1.38	1.72	1.95	2.05	0.9	2.08	2.57	3.02	4.78	4.81	3.74	3.94	4.64
Basic EPS, GAAP	3.01	3.78	1.66	1.51	3	0.95	0.27	1.35	2.09	2.54	4.01	3.99	3.3	7.74	3.76
Basic EPS from Cont Ops	0.72	0.15	1.28	1.14	1.77	0.72	0.2	1.33	2.09	2.52	4.01	3.99	3.3	7.74	3.76
Diluted EPS, GAAP	3.01	3.75	1.64	1.5	2.94	0.94	0.27	1.34	2.07	2.52	3.95	3.93	3.27	7.67	3.73
Diluted EPS from Cont Ops	0.72	0.15	1.26	1.13	1.73	0.72	0.2	1.32	2.07	2.5	3.95	3.93	3.27	7.67	3.73
Dividend per Share	1.87	2.02	0.57	0.89	0.98	1.04	1.06	1.12	1.29	1.45	1.82	1.9	2.05	2.22	2.37
Cash Flow per Share	5.71	5.91	2.15	2.44	2.01	2.17	3.19	3.59	3.48	4.46	5.97	5.51	4.19	4.94	5.51
Free Cash Flow per Basic Share	4.76	4.77	1.41	1.72	1.26	1.41	2.54	2.79	2.55	3.23	4.9	4.49	2.92	3.67	4.26
Cash & Equivalents per Share	5.16	9.62	5.23	2.96	4.16	12.75	5.51	2.33	2.35	4.04	5.81	5.85	4.2	4.6	5.15
Book Value per Share	19.57	22.77	21.98	23.38	26.14	26.2	27.06	27.38	28.2	29.23	31.74	34.51	36	41.82	43.37
Tangible Book Value per Share	-0.74	1.55	6.3	3.56	4.16	5.77	-8.26	-6.54	-5.06	-3.12	0.03	2.1	3.65	10.48	13.37

Abbott Laboratories

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)